These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23840194)

  • 41. A Bioengineered Human Skin Tissue for the Treatment of Infected Wounds.
    Thomas-Virnig CL; Allen-Hoffmann BL
    Adv Wound Care (New Rochelle); 2012 Apr; 1(2):88-94. PubMed ID: 24527286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinically Addressing Biofilm in Chronic Wounds.
    Attinger C; Wolcott R
    Adv Wound Care (New Rochelle); 2012 Jun; 1(3):127-132. PubMed ID: 24527292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current State and Promising Opportunities on Pharmaceutical Approaches in the Treatment of Polymicrobial Diseases.
    Sartini S; Permana AD; Mitra S; Tareq AM; Salim E; Ahmad I; Harapan H; Emran TB; Nainu F
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33672615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants.
    Mirzaee M; Holásková E; Mičúchová A; Kopečný DJ; Osmani Z; Frébort I
    Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of low-level laser therapy on the dynamics of pressure ulcer-induced changes considering an infectious agent and cathelicidin LL-37 concentration: a preliminary study.
    Brauncajs M; Ksiąszczyk K; Lewandowska-Polak A; Gorzela K; Grzegorczyk J
    Postepy Dermatol Alergol; 2018 Dec; 35(6):582-586. PubMed ID: 30618525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Old Polyanionic Drug Suramin Suppresses Detrimental Cytotoxicity of the Host Defense Peptide LL-37.
    Quemé-Peña M; Ricci M; Juhász T; Horváti K; Bősze S; Biri-Kovács B; Szeder B; Zsila F; Beke-Somfai T
    ACS Pharmacol Transl Sci; 2021 Feb; 4(1):155-167. PubMed ID: 33615169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutrophils and Wound Repair: Positive Actions and Negative Reactions.
    Wilgus TA; Roy S; McDaniel JC
    Adv Wound Care (New Rochelle); 2013 Sep; 2(7):379-388. PubMed ID: 24527354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unnatural Amino-Acid-Based Star-Shaped Poly(l-Ornithine)s as Emerging Long-Term and Biofilm-Disrupting Antimicrobial Peptides to Treat Pseudomonas aeruginosa-Infected Burn Wounds.
    Pan M; Lu C; Zheng M; Zhou W; Song F; Chen W; Yao F; Liu D; Cai J
    Adv Healthc Mater; 2022 Jun; 11(11):e2200944. PubMed ID: 35673888
    [No Abstract]   [Full Text] [Related]  

  • 49. LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities.
    Santos J; Ventura S; Pallarès I
    Neural Regen Res; 2023 May; 18(5):1027-1028. PubMed ID: 36254986
    [No Abstract]   [Full Text] [Related]  

  • 50. Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.
    Girnita A; Zheng H; Grönberg A; Girnita L; Ståhle M
    Oncogene; 2023 Feb; 42(8):626. PubMed ID: 36494433
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of Infected Wounds.
    Lanphear E
    Tex Med J (Austin); 1907 Aug; 23(2):43-47. PubMed ID: 36956264
    [No Abstract]   [Full Text] [Related]  

  • 52. Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37.
    Chung MC; Dean SN; van Hoek ML
    Biochem J; 2015 Sep; 470(2):243-53. PubMed ID: 26188040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unique features of human cathelicidin LL-37.
    Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
    Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine.
    Xhindoli D; Morgera F; Zinth U; Rizzo R; Pacor S; Tossi A
    Biochem J; 2015 Feb; 465(3):443-57. PubMed ID: 25378136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37.
    Xhindoli D; Pacor S; Guida F; Antcheva N; Tossi A
    Biochem J; 2014 Jan; 457(2):263-75. PubMed ID: 24117320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions.
    Kopfnagel V; Harder J; Werfel T
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):531-6. PubMed ID: 23974683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of salivary lactoperoxidase and histatin-5 on early childhood caries severity in relation to nutritional status.
    Munther S
    Saudi Dent J; 2020 Dec; 32(8):410-416. PubMed ID: 33304085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can Salivary Biomarkers Be Used as Predictors of Dental Caries in Young Adolescents?
    Stojković B; Igić M; Jevtović Stoimenov T; Tričković Janjić O; Ignjatović A; Kostić M; Petrović M; Stojanović S
    Med Sci Monit; 2020 Jun; 26():e923471. PubMed ID: 32518218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential applications of antimicrobial peptides and their mimics in combating caries and pulpal infections.
    Mai S; Mauger MT; Niu LN; Barnes JB; Kao S; Bergeron BE; Ling JQ; Tay FR
    Acta Biomater; 2017 Feb; 49():16-35. PubMed ID: 27845274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral antimicrobial peptides: Types and role in the oral cavity.
    Khurshid Z; Naseem M; Sheikh Z; Najeeb S; Shahab S; Zafar MS
    Saudi Pharm J; 2016 Sep; 24(5):515-524. PubMed ID: 27752223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.